Medical Stocks In the News: XRTX, HALB, IPA.V / IPA, RSHN, THRM.V / TBRIF

Getting your Trinity Audio player ready...

This morning some stocks have managed to come on to the radars of investors and it may be a good move for investors to take a look into those lest they miss out on some sound opportunities. Even as the trading activities for the day go into overdrive, it is still necessary for investors to continue to look into stocks that may be making the news and then make their choices accordingly. This article gives you a glimpse into some stocks which are in focus this morning. Here is a look at three stocks that you would track today.

Halberd Corporation (OTCMKTS:HALB) – The Halberd Corporation is a healthcare company that has accomplished considerable research work over the course of the past months and this morning the stock has clocked gains of as much as 9% amidst considerable interest.

Yesterday, the company was actually in the news after its Chief Executive Officer sent out a letter highlighting the company’s achievements and set out the expectations for the rest of 2022. While the accomplishments so far from the company were impressive in their own right, the letter noted that the company was going to stay committed to its journey in which it was going to work on the development of treatments for neurodegenerative diseases.

It was also noted that in the next stage of the company’s evolution Halberd was going to be involved in animal testing of its patented extracorporeal eradication process. It may be a good idea to keep the stock on your watch lists for now.

Immunoprecise Antibodies Ltd (NASDAQ:IPA) (CVE:IPA) – Advanced Biotherapeutics research and technology firm IPA is another company that was in the news yesterday and hence, its stock may come into focus among investors today.

Yesterday, the company reported critical third-party findings in relation to its two IND-powered pre-clinical safety studies. The findings from the study proved to be positive and that is something that investors ought to keep in mind when they consider the stock.

The study in question looked into the possibility of deploying the antibody cocktail from the company named PolyTope® TATX-03 for tackling COVID-19 and the findings were positive. At a time when COVID-19 cases are rising again, it may be looked upon as a major positive for IPA.

XORTX Therapeutics Inc (NASDAQ:XRTX) – Last but certainly not least, it is XORTX Therapeutics Inc, which may be looked into today after its stock soared by as much as 103% today’s trading owing to a key announcement from the company.

The rally came about after the company announced the findings from the first part of the Pharmacokinetics Bridging Study into its product XRX-OXY-101. It may now be a good time to keep an eye on the stock.

Therma Bright (TSX.V : THRM) (OTCQB:TBRIF) is a stock to watch as it is trading at a historical discount. Therma Bright Inc is best known for having developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test and is also working on a range of other medical devices.

Recently, the company was in the news once again after it announced that it had awarded options to many of the directors, consultants, and officers to pick up a total of as many as 1,475,000 common shares in the company. It is part of the wider share options plan at Therma Bright.

Rushnet / heliosDX (OTC:RSHN) – is another medical company that investors could consider looking into this week is of RushNet. Earlier this week, the company announced that it had gone into collaboration with Sciteck Diagnostics.

As per the provisions of the collaboration, RushNet would adopt the AutoUA reagent system from Sciteck so as to tackle Kidney Disease and related conditions. However, a special focus is going to be accorded to urinary tract infections.